肌肌酸激酶(CKM)重組蛋白
Recombinant Creatine Kinase, Muscle (CKM)
CK-MM; CKMM; CK3; CK-M; MM-CK; M-CK; Creatine kinase M-type, N-terminally processed
- 編號RPA109Bo01
- 物種Bos taurus; Bovine (Cattle,牛) 相同的名稱,不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位n/a
- 預(yù)測分子量-
- 實(shí)際分子量-(差異分析請參閱說明書)
- 片段與標(biāo)簽N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)-
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 984 ¥ 2460 ¥ 4920 ¥ 14760 ¥ 36900
- 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
PBS或其它。
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Bos taurus; Bovine (Cattle,牛) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA109Bo01 | 肌肌酸激酶(CKM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA109Bo01 | 肌肌酸激酶(CKM)多克隆抗體 | WB; IHC; ICC; IP. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Journal of Inflammation | Assessment of endothelium and inflammatory response at the onset of reperfusion injury in hand surgery [PubMed: 22583529] |
PLoS One | Extraocular Muscle Characteristics Related to Myasthenia Gravis Susceptibility [PubMed: PMC3568149] |
Kidney Int. | Fructokinase activity mediates dehydration-induced renal injury [Pubmed: 24336030] |
Methylxanthines and cardiotoxicity | Methylxanthine induced cardiotoxicity and its mechanisms: An experimental study [230b:34bf146150b42971d76dda5e8329bc5f2f0b.pdf] |
Molecular Medicine Reports | Protective effects of N (2)?L?alanyl?L?glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion [Pubmed:29393473] |
Toxicological?Sciences | Proteomic and Metabolomic Profiling Identify Plasma Biomarkers for Exposure to Ultra-low Levels of Carfentanil [Pubmed: 30321427] |
Clinical & Translational Oncology | The effects of human sera conditioned by high-intensity exercise sessions and training on the tumorigenic potential of cancer cells [Pubmed: 32447643] |
留言咨詢